FindTrial
Sign In

A randomized controlled study of acupuncture and moxibustion in the treatment of dry age-related macular degeneration

A randomized controlled study of acupuncture and moxibustion in the treatment of dry age-related macular degeneration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039822
Enrollment
Unknown
Registered
2020-11-11
Start date
2019-03-18
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related macular degeneration

Interventions

Acupuncture group:The patient took the lying position, and after routine skin disinfection, a 0.18*25mm disposable stainless steel needle was used to acupuncture the affected side Jingming and Chengqi
Acupuncture with wheat grain moxibustion group:The patient takes the lying position and after routine skin disinfection, a disposable stainless steel needle with a specification of 0.18*25mm is used t
Conventional treatment:Oral Mecobalamin (Mecobalamin Tablets), 1 tablet (0.5mg) each time, 3 times a day, the therapeutic effect will be evaluated after 3 months of treatment

Sponsors

The Third Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Any eye of the subject meets the diagnostic criteria for dry age-related macular degeneration, and the corrected visual acuity of the affected eye <= 0.9; (2) Patients with dry age-related macular degeneration without other eye diseases; (3) No related treatment for dry age-related macular degeneration within four weeks; (4) The patient himself signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Corrected vision >=1.0; (2) Fluorescein fundus angiography does not support age-related macular degeneration; (3) Fluorescein fundus angiography showed a single or scattered serous degeneration of the pigment epithelium at the macular or posterior pole; Less than 1/3 of the optic disc; (4) Those who have other fundus diseases and cannot see the fundus clearly; (5) Past history of macular degeneration, unable to distinguish whether it is age-related macular degeneration.

Design outcomes

Primary

MeasureTime frame
Best corrected vision;Amsler checkered table check;Macular Center Thickness;Direct ophthalmoscope;—

Countries

China

Contacts

Public ContactZhang Quanai

The Third Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine

lhy45656@126.com+86 15158065851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026